My Derm is Malaysias first personalized human skin substitute meant for permanent repair of full thickness skin loss, clinically proven to actively enhance wound healing. MyDerm R&D was finalized in June 2008 through Big Animal Study and Limited Clinical Application after undergoing several proof of concept testing. National level of Clinical Trials has just been recently completed in K+UKM Medical Centre to a positive review. My Derm offers ultimate alternative for treatments of chronic non-healing ulcers, severe burns, skin trauma (to name a few) in replacement of the current gold standard treatment, called Split Skin Graft (SSG). SSG is potentially known to cause physical and emotional trauma to patients as skin from unwounded body part is taken and used to cover the wounded area. While success rate is still 50-50, SSG is extremely limited by patients available skin. This is where MyDerm stands out, providing less painful but greater outcome for patients primarily because it covers whatever size of wound the patient has, while making sure the healing rate is significantly increased. Being autologous, MyDerm uses patients own skin cells as main ingredients, ensuring no rejection upon application. MyDerm also mimics real skin which means it is both physically and mechanically similar to the host skin, with growth factors, proteins and other related biochemical. Having all these unique proprietary technology, MyDerm ensures effectiveness of treatment up to 90% and therefore it is accepted by surgeons and doctors as the most ideal skin substitute.